Baxion
ScreeningTagsAlerts

Odyssey Therapeutics, Inc.

ODTX·NASDAQ·$17.56Share Price as of 11/2·$507MMarket Cap as of 11/2

Financials

10-QQuarter ended 06/30/2608/06/2610-QQuarter ended 03/31/2606/17/26

Disclosures

8-KCurrent report10/20/268-KCurrent report09/09/268-KCurrent report08/04/268-KCurrent report06/23/268-KCurrent report06/17/26

Prospectuses and Registrations

S-8Registration of securities for employees05/11/26424B4Prospectus05/08/26S-1MEFProspectus / registration05/07/26S-1/ARegistration statement (amended)05/04/26S-1Registration statement (IPO)04/17/26

Proxies

No matching filings.

Ownership

SC 13GBeneficial ownership06/05/26SC 13DBeneficial ownership05/18/26SC 13DBeneficial ownership05/18/26SC 13GBeneficial ownership05/18/26SC 13DBeneficial ownership05/15/26

Other

CERTCEO/CFO certification05/07/26EFFECTRequest for effectiveness05/07/268-A12B8-A12B05/05/26DRS/ADRS/A04/03/26DRS/ADRS/A03/16/26

Latest Filings

8-KCurrent report10/20/268-KCurrent report09/09/2610-QQuarter ended 06/30/2608/06/268-KCurrent report08/04/268-KCurrent report06/23/26

Ownership

SC 13GBeneficial ownership06/05/26SC 13DBeneficial ownership05/18/26SC 13DBeneficial ownership05/18/26SC 13GBeneficial ownership05/18/26SC 13DBeneficial ownership05/15/26
  • Baxion © 2026
  • Terms
  • Privacy
  • Contact